Metabolic profiling of PPARα −/− mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation
Open accessThe DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Abstract
Peroxisome proliferator‐activated receptor‐α (PPARα) is a master transcriptional regulator of β‐oxidation and a prominent target of hypolipidemic drugs. To gain deeper insights into the systemic consequences of impaired fat catabolism we used quantitative, mass spectrometry‐based metabolic profiling to investigate the fed‐to‐fasted transition in PPARα +/+ and PPARα −/− mice. Compared to PPARα +/+ animals' acylcarnitine profiles of PPARα −/− mice revealed 2‐ to 4‐fold accumulation of long‐chain species in the plasma' whereas short‐chain species were reduced by as much as 69% in plasma, liver, and skeletal muscle. These results reflect a metabolic bottleneck downstream of carnitine palmitoyltransferase‐1, a mitochondrial enzyme that catalyzes the first step in β‐oxidation. Organic and amino acid profiles of starved PPARα −/− mice suggested compromised citric acid cycle fluX, enhanced urea cycle activity, and increased amino acid catabolism. PPARα −/− mice had 40‐50% lower plasma and tissue levels of free carnitine, corresponding with diminished hepatic expression of genes involved in carnitine biosynthesis and transport. One week of oral carnitine supplementation conferred partial metabolic recovery in the PPARα −/− mice. In summary, comprehensive metabolic profiling revealed novel biomarkers of defective fat oxidation, while also highlighting the potential value of supplemental carnitine as a therapy and diagnostic tool for metabolic disorders.—Makowski, L., Noland, R. C., Koves, T. R., Xing, W., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., Muoio, D. M. Metabolic profiling of PPARα −/− mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J. 23, 586‐604 (2009)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent studies in PPAR␣ null mice confirmed an essential role for this nuclear receptor in regulating carnitine homeostasis, because these animals have a profound systemic carnitine deficiency associated with reduced hepatic expression of OCTN2 and ␥-butyrobetaine hydrox-ylase-1 (35,36).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [36]
Citations
Cites
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990 · cited 2×
“increase -oxidation in the postabsorptive state (6).”
MethodSelf-citationCahill, G. F. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111258 · Cited by 1,319
Peroxisome proliferator-activated receptor a target genes
Mandard, S., M�ller, M., & Kersten, S. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3216-3 · Cited by 1,218
Kelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096
Tanaka, M., Yamamoto, Y., Misawa, E., Nabeshima, K., Saito, M., Yamauchi, K., Abe, F., & Furukawa, F. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000454718 · Cited by 1,092
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020
Reddy, J. K., & Hashimoto, T. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.193 · Cited by 959
Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954
Hypoxia-Inducible Factor 1 (HIF-1) Pathway
Semenza, G. L. (2007) · Science's STKE · doi:10.1126/stke.4072007cm8 · Cited by 945 · cited 1×
“An intriguing candidate for such signal is -ketoglutarate, a critical metabolic intermediate that also plays a role in stress response via its regulation of the hypoxia-inducible factors (HIF) 1 and 2 (33, 34).”
BackgroundLeone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., & Gonzalez, F. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5678 · Cited by 863
Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., Kuller, L. H., Broudeau, R., Kammerer, C., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2537 · Cited by 766
Carnitine biosynthesis in mammals
Vaz, F. M., & Wanders, R. J. A. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610417 · Cited by 764
Sarcopenic obesity and inflammation in the InCHIANTI study
Schrager, M. A., Metter, E. J., Simonsick, E., Ble, A., Bandinelli, S., Lauretani, F., & Ferrucci, L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00627.2006 · Cited by 594 · cited 1×
“Muscle atrophy occurring in the setting of central obesity has been linked to proinflammatory mediators such as TNF- , interleukin-6 (IL-6), C-reactive protein, interleukin-1 receptor antagonist, and soluble IL-6 receptor (43, 44).”
BackgroundAragonés, J., Schneider, M., Van Geyte, K., Fraisl, P., Dresselaers, T., Mazzone, M., Dirkx, R., Zacchigna, S., Lemieux, H., Jeoung, N. H., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.62 · Cited by 472 · cited 1×
“These transcription factors can be activated by hypoxia, glucose deprivation, or cellular depletion of -ketoglutarate, and, in turn, regulate a program of genes that compensate for oxygen deficit and/or other metabolic crises (35, 36).”
BackgroundPhysical frailty and body composition in obese elderly men and women
Villareal, D. T., Banks, M., Siener, C., Sinacore, D. R., & Klein, S. (2004) · Obesity Research · doi:10.1038/oby.2004.111 · Cited by 459
An, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., & Newgard, C. B. (2004) · Nature Medicine · doi:10.1038/nm995 · Cited by 450 · cited 1×
“Methods for sample preparation are as described previously (17).”
MethodSelf-citationHashimoto, T., Cook, W. S., Qi, C., Yeldandi, A. V., Reddy, J. K., & Rao, M. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910350199 · Cited by 444
Muoio, D. M., MacLean, P. S., Lang, D. B., Li, S., Houmard, J. A., Way, J. M., Winegar, D. A., Corton, J. C., Dohm, G. L., & Kraus, W. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203997200 · Cited by 398
Self-citationMolecular enzymology of carnitine transfer and transport
Ramsay, R. R., Gandour, R. D., & van der Leij, F. R. (2001) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(01)00147-9 · Cited by 389 · cited 1×
“Carnitine is a conditionally essential nutrient necessary for mitochondrial import and export of acyl-CoAs (14).”
BackgroundMacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359 · cited 1×
“An intriguing candidate for such signal is -ketoglutarate, a critical metabolic intermediate that also plays a role in stress response via its regulation of the hypoxia-inducible factors (HIF) 1 and 2 (33, 34).”
BackgroundObesity-related derangements in metabolic regulation
Muoio, D. M., & Newgard, C. B. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142512 · Cited by 345 · cited 1×
“tribute to the development of metabolic disease (2, 3).”
BackgroundSelf-citationPatsouris, D., Reddy, J. K., Müller, M., & Kersten, S. (2006) · Endocrinology · doi:10.1210/en.2005-1132 · Cited by 340
ROUBENOFF, R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06515.x · Cited by 230
Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study
Sayer, A. A., Syddall, H. E., Dennison, E. M., Martin, H. J., Phillips, D. I. W., Cooper, C., & Byrne, C. D. (2007) · QJM · doi:10.1093/qjmed/hcm095 · Cited by 214
The peroxisome proliferator‐activated receptor α regulates amino acid metabolism
KERSTEN, S., MANDARD, S., ESCHER, P., GONZALEZ, F. J., TAFURI, S., DESVERGNE, B., & WAHLI, W. (2001) · The FASEB Journal · doi:10.1096/fj.01-0147com · Cited by 203
Gramignano, G., Lusso, M. R., Madeddu, C., Massa, E., Serpe, R., Deiana, L., Lamonica, G., Dessì, M., Spiga, C., Astara, G., et al. (2006) · Nutrition · doi:10.1016/j.nut.2005.06.003 · Cited by 167
Zambon, A., Gervois, P., Pauletto, P., Fruchart, J.-C., & Staels, B. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000204327.96431.9a · Cited by 162
Finck, B. N., & Kelly, D. P. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2061 · Cited by 160
Atherton, H. J., Bailey, N. J., Zhang, W., Taylor, J., Major, H., Shockcor, J., Clarke, K., & Griffin, J. L. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00060.2006 · Cited by 159
Xu, J., Xiao, G., Trujillo, C., Chang, V., Blanco, L., Joseph, S. B., Bassilian, S., Saad, M. F., Tontonoz, P., Lee, W. N. P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201208200 · Cited by 157
A Novel Disease with Deficiency of Mitochondrial Very-Long-Chain Acyl-CoA Dehydrogenase
Aoyama, T., Uchida, Y., Kelley, R. I., Marble, M., Hofman, K., Tonsgard, J. H., Rhead, W. J., & Hashimoto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1368 · Cited by 150
Compensatory Responses to Pyruvate Carboxylase Suppression in Islet β-Cells
Jensen, M. V., Joseph, J. W., Ilkayeva, O., Burgess, S., Lu, D., Ronnebaum, S. M., Odegaard, M., Becker, T. C., Sherry, A. D., & Newgard, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604350200 · Cited by 144
Self-citationPossible beneficial role of exercise in modulating low‐grade inflammation in the elderly
Pedersen, B. K., & Bruunsgaard, H. (2003) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1034/j.1600-0838.2003.20218.x · Cited by 133 · cited 1×
“Muscle atrophy occurring in the setting of central obesity has been linked to proinflammatory mediators such as TNF- , interleukin-6 (IL-6), C-reactive protein, interleukin-1 receptor antagonist, and soluble IL-6 receptor (43, 44).”
BackgroundTurnbull, D. M., Bartlett, K., Stevens, D. L., Alberti, K. G. M. M., Gibson, G. J., Johnson, M. A., McCulloch, A. J., & Sherratt, H. S. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411083111906 · Cited by 132
Siddiq, A., Aminova, L. R., & Ratan, R. R. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9268-7 · Cited by 129 · cited 1×
“These transcription factors can be activated by hypoxia, glucose deprivation, or cellular depletion of -ketoglutarate, and, in turn, regulate a program of genes that compensate for oxygen deficit and/or other metabolic crises (35, 36).”
BackgroundCardiac hypertrophy is enhanced in PPAR -/- mice in response to chronic pressure overload
Smeets, P. J. H., Teunissen, B. E. J., Willemsen, P. H. M., van Nieuwenhoven, F. A., Brouns, A. E., Janssen, B. J. A., Cleutjens, J. P. M., Staels, B., van der Vusse, G. J., & van Bilsen, M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn001 · Cited by 126
Carnitine revisited: potential use as adjunctive treatment in diabetes
Power, R. A., Hulver, M. W., Zhang, J. Y., Dubois, J., Marchand, R. M., Ilkayeva, O., Muoio, D. M., & Mynatt, R. L. (2007) · Diabetologia · doi:10.1007/s00125-007-0605-4 · Cited by 113 · cited 1×
“ease, cancer, and type 2 diabetes (62, 64, 65).”
Self-citationvan VLIES, N., TIAN, L., OVERMARS, H., BOOTSMA, A. H., KULIK, W., WANDERS, R. J. A., WOOD, P. A., & VAZ, F. M. (2005) · Biochemical Journal · doi:10.1042/bj20041489 · Cited by 111
IL-6-Like Cytokines and Cancer Cachexia: Consequences of Chronic Inflammation
Barton, B. E. (2001) · Immunologic Research · doi:10.1385/ir:23:1:41 · Cited by 110
Diet-induced obesity alters protein synthesis: tissue-specific effects in fasted versus fed mice
Anderson, S. R., Gilge, D. A., Steiber, A. L., & Previs, S. F. (2008) · Metabolism · doi:10.1016/j.metabol.2007.10.009 · Cited by 109
Nutrient Signaling Components Controlling Protein Synthesis in Striated Muscle ,
Vary, T. C., & Lynch, C. J. (2007) · Journal of Nutrition · doi:10.1093/jn/137.8.1835 · Cited by 108
Owen, K. Q., Jit, H., Maxwell, C. V., Nelssen, J. L., Goodband, R. D., Tokach, M. D., Tremblay, G. C., & Koo, S. I. (2001) · Journal of Animal Science · doi:10.2527/2001.79123104x · Cited by 101
van Vlies, N., Ferdinandusse, S., Turkenburg, M., Wanders, R. J. A., & Vaz, F. M. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.07.001 · Cited by 98
Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency.
Kelly, D. P., Whelan, A. J., Ogden, M. L., Alpers, R., Zhang, Z. F., Bellus, G., Gregersen, N., Dorland, L., & Strauss, A. W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9236 · Cited by 89
Thyfault, J. P., Cree, M. G., Zheng, D., Zwetsloot, J. J., Tapscott, E. B., Koves, T. R., Ilkayeva, O., Wolfe, R. R., Muoio, D. M., & Dohm, G. L. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00311.2006 · Cited by 87
Self-citationBasic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus
Blaak, E. E. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2004361 · Cited by 83
Gloerich, J., van Vlies, N., Jansen, G. A., Denis, S., Ruiter, J. P. N., van Werkhoven, M. A., Duran, M., Vaz, F. M., Wanders, R. J. A., & Ferdinandusse, S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400337-jlr200 · Cited by 80
Primaßin, S., ter Veld, F., Mayatepek, E., & Spiekerkoetter, U. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e31816ff6f0 · Cited by 76 · cited 1×
“The observed elevations in plasma carnitine are consistent with published values (15).”
ResultA comparative metabolomic study of NHR‐49 in Caenorhabditis elegans and PPAR‐α in the mouse
Atherton, H. J., Jones, O. A. H., Malik, S., Miska, E. A., & Griffin, J. L. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.04.020 · Cited by 74
Edgar, A. D., Tomkiewicz, C., Costet, P., Legendre, C., Aggerbeck, M., Bouguet, J., Staels, B., Guyomard, C., Pineau, T., & Barouki, R. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00042-3 · Cited by 71
Siami, G., Clinton, M. E., Mrak, R., Griffis, J., & Stone, W. (1991) · Nephron · doi:10.1159/000186280 · Cited by 70
Mansouri, R. M., Baugé, E., Staels, B., & Gervois, P. (2008) · Endocrinology · doi:10.1210/en.2007-1339 · Cited by 61
Koch, A., König, B., Stangl, G. I., & Eder, K. (2008) · Experimental Biology and Medicine · doi:10.3181/0706-rm-168 · Cited by 61
Sheikh, K., Camejo, G., Lanne, B., Halvarsson, T., Landergren, M. R., & Oakes, N. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00254.2006 · Cited by 60
Hardy, O. T., Hohmeier, H. E., Becker, T. C., Manduchi, E., Doliba, N. M., Gupta, R. K., White, P., Stoeckert, C. J., Matschinsky, F. M., Newgard, C. B., et al. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0411 · Cited by 59
Assay for Free and Total Carnitine in Human Plasma Using Tandem Mass Spectrometry
Stevens, R. D., Hillman, S. L., Worthy, S., Sanders, D. C., & Millington, D. S. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.5.727 · Cited by 58 · cited 1×
“For all metabolites except acyl-CoAs, the tissue was ground in a liquid nitrogen chilled mortar and pestle, and 50 mg was suspended in water, homogenized on ice, sonicated, and finally spun 15 min at 4°C, 14,000 rpm (16).”
MethodSelf-citationSatapati, S., He, T., Inagaki, T., Potthoff, M., Merritt, M. E., Esser, V., Mangelsdorf, D. J., Kliewer, S. A., Browning, J. D., & Burgess, S. C. (2008) · Diabetes · doi:10.2337/db08-0226 · Cited by 52
Xu, J., Chang, V., Joseph, S. B., Trujillo, C., Bassilian, S., Saad, M. F., Lee, W. N. P., & Kurland, I. J. (2004) · Endocrinology · doi:10.1210/en.2003-1173 · Cited by 50
Ringseis, R., POSEL, S., Hirche, F., & Eder, K. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.06.001 · Cited by 49
Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers
Giovenali, P., Fenocchio, D., Montanari, G., Cancellotti, C., D'Iddio, S., BUONCRISTIANI, U., Pelagaggia, M., & Ribacchi, R. (1994) · Kidney International · doi:10.1038/ki.1994.460 · Cited by 46
Moody, D. E., & Reddy, J. K. (1974) · PubMed · Cited by 44
Interleukin-6 stimulates gluconeogenesis in primary cultures of rat hepatocytes
Blumberg, D., Hochwald, S. N., Brennan, M. F., & BURT, M. E. (1995) · Metabolism · doi:10.1016/0026-0495(95)90255-4 · Cited by 39
Bhuiyan, A. K. M., Bartlett, K., Sherratt, H. S. A., & Agius, L. (1988) · Biochemical Journal · doi:10.1042/bj2530337 · Cited by 38
Murakami, K., Bujo, H., Unoki‐Kubota, H., & Saitō, Y. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.037 · Cited by 38
Biolo, G., Stulle, M., Bianco, F., Mengozzi, G., Barazzoni, R., Vasile, A., Panzetta, G., & Guarnieri, G. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm664 · Cited by 38 · cited 1×
“ease, cancer, and type 2 diabetes (62, 64, 65).”
Targeted Disruption of the Peroxisome Proliferator—Activated Receptor α Gene, PPARα
Lee, S. S. T., & Gonzalez, F. J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18642.x · Cited by 35
Metabolic Inflexibility in Skeletal Muscle: A Prelude to the Cardiometabolic Syndrome?
Thyfault, J. P., Rector, R. S., & Noland, R. C. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05629.x · Cited by 31 · cited 1×
“tribute to the development of metabolic disease (2, 3).”
BackgroundSelf-citationASAI, T., Okumura, K., TAKAHASHI, R., MATSUI, H., Numaguchi, Y., Murakami, H., Murakami, R., & Murohara, T. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.005 · Cited by 22
Mechanism of increased hepatic concentration of carnitine by clofibrate
Paul, H. S., Gleditsch, C. E., & Adibi, S. A. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.251.3.e311 · Cited by 22
Steiber, A. L., Weatherspoon, L., Spry, L., & Davis, A. T. (2003) · Clinical Nutrition · doi:10.1016/s0261-5614(03)00085-2 · Cited by 20 · cited 1×
“Carnitine depletion has also been shown to correlate negatively with muscle mass and function (42).”
Background
Research works printed but not linked: 1
- 10.1042/bj3610417 · DOI · Paper page
Cited by
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020
“Amino Acid metabolism ABAT [24, 159], Acmsd [159], AGXT2 [24, 160], Arg1 [160], ASL [24, 160], Ass1 [160], CBS [24, 159], CPS-1 [24, 160], Cth [159], Got1 [160], Got2 [62, 64, 160, 161], Gls [160], GLS2 [159], GPT [24, 159], Hal [159], Hpd [159], OAT [24, 159], ODC1 [24, 62, 159], OTC [24, 62, 160], PAH [24, 159], PSA…”
BackgroundIntegrated physiology and systems biology of PPARα
Kersten, S. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.002 · Cited by 670
“Furthermore, plasma levels of long chain acyl-carnitines are increased in fasted PPARa / mice, whereas plasma levels of medium and short chain acyl-carnitines and free carnitine are decreased, reflecting impaired fatty acid oxidation (Table 1) [21,27].”
BackgroundInfluentialBedi, K. C., Snyder, N. W., Brandimarto, J., Aziz, M., Mesaros, C., Worth, A. J., Wang, L. L., Javaheri, A., Blair, I. A., Margulies, K. B., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017545 · Cited by 650
The inflammation highway: metabolism accelerates inflammatory traffic in obesity
Johnson, A. R., Justin Milner, J., & Makowski, L. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01151.x · Cited by 603
Self-citationEllis, J. M., Li, L. O., Wu, P.-C., Koves, T. R., Ilkayeva, O., Stevens, R. D., Watkins, S. M., Muoio, D. M., & Coleman, R. A. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.012 · Cited by 357
“Long-chain acyl-carnitines accumulate when their production by mitochondrial CPT1 exceeds their flux through b-oxidation (Makowski et al., 2009).”
Self-citation
Metadata
- Authors
- Makowski, L., Noland, R. C., Koves, T. R., Xing, W., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., & Muoio, D. M.
- Affiliations
- Duke University (US)
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2008-10-22
- Volume
- 23
- Issue
- 2
- Pages
- 586-604
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC2630792
- OpenAlex
- W2062936856
- Cited by
- 113
- References
- 71
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 8 · 2014: 11 · 2013: 10 · 2012: 12
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (P30‐AG028716, K99‐AA017376‐01, F32‐DK080609)
- American Diabetes Association
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- PPARα, L-carnitine, acylcarnitines, carnitine palmitoyltransferase 1, fatty acid beta-oxidation, fat oxidation, amino acid homeostasis, urea cycle, TCA cycle, carnitine biosynthesis, carnitine supplementation, fasting, metabolite profiling, PPARα knockout mice
- MeSH terms
- Acylation, Administration, Oral, Amino Acids, Animals, Animal Feed, Carnitine, Hot Temperature, Homeostasis, Male, Mice, Knockout, Muscle, Skeletal, PPAR alpha, Mice, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.